Cargando…
Recent advances in the treatment of non-small cell and small cell lung cancer
Recent presentations at the American Society of Clinical Oncology (ASCO) meeting from 30 May to 3 June, 2014, will impact routine clinical care and the development of clinical trials in non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (ES-SCLC). Patients with activating...
Autor principal: | Stinchcombe, Thomas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251418/ https://www.ncbi.nlm.nih.gov/pubmed/25580271 http://dx.doi.org/10.12703/P6-117 |
Ejemplares similares
-
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
por: Stinchcombe, Thomas E
Publicado: (2007) -
Current management of RET rearranged non-small cell lung cancer
por: Stinchcombe, Thomas E
Publicado: (2020) -
Recent advances in the management of non-small cell lung cancer
por: Shojaee, Samira, et al.
Publicado: (2017) -
Narrative review: blood and tumor biomarker testing in non-small cell lung cancer without an oncogenic driver
por: Stinchcombe, Thomas E.
Publicado: (2023) -
Recent advances of novel targeted therapy in non-small cell lung cancer
por: Katzel, Jed A, et al.
Publicado: (2009)